# 117-hr-7032: Increasing Transparency in Generic Drug Applications Act of 2022

117-hr-7032, Increasing Transparency in Generic Drug Applications Act of 2022, is a 117th Congress bill sponsored by Rep. Kuster, Ann M. [D-NH-2] (D-NH); status Referred to the Subcommittee on Health. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/117-hr-7032
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 117-hr-7032
- Congress: 117
- Title: Increasing Transparency in Generic Drug Applications Act of 2022
- Status: Referred to the Subcommittee on Health.
- Introduced: 2022-03-09
- Sponsor: Rep. Kuster, Ann M. [D-NH-2] (D-NH)
- Cosponsors: 1
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Increasing Transparency in Generic Drug Applications Act of 2022 This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

## Cosponsors (1)

- Rep. Schrier, Kim [D-WA-8] (D-WA), 2022-04-01T00:00:00.000Z

## Related bills

- 117-hr-4693: Global Malnutrition Prevention and Treatment Act of 2021
- 117-hr-1667: Dr. Lorna Breen Health Care Provider Protection Act
- 117-hr-3537: Accelerating Access to Critical Therapies for ALS Act
- 117-hr-1437: Further Continuing Appropriations and Extensions Act, 2023
- 117-hr-7791: Access to Baby Formula Act of 2022
- 117-hr-1193: Cardiovascular Advances in Research and Opportunities Legacy Act

## Sources
- [117-hr-7032 on Congress.gov](https://www.congress.gov/bill/117th-congress/house-bill/7032)

## Related
- [117-hr-4693: Global Malnutrition Prevention and Treatment Act of 2021](https://policyrisk.com/legislation/117-hr-4693)
- [117-hr-1667: Dr. Lorna Breen Health Care Provider Protection Act](https://policyrisk.com/legislation/117-hr-1667)
- [117-hr-3537: Accelerating Access to Critical Therapies for ALS Act](https://policyrisk.com/legislation/117-hr-3537)
- [117-hr-1437: Further Continuing Appropriations and Extensions Act, 2023](https://policyrisk.com/legislation/117-hr-1437)
- [117-hr-7791: Access to Baby Formula Act of 2022](https://policyrisk.com/legislation/117-hr-7791)
- [117-hr-1193: Cardiovascular Advances in Research and Opportunities Legacy Act](https://policyrisk.com/legislation/117-hr-1193)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/117-hr-7032 (as of 2025-11-18).